New Two-Pronged cancer drug enters human trials
NCT ID NCT04977453
Summary
This study is testing the safety and effectiveness of a new investigational drug called GI-101 for people with advanced or metastatic solid tumors. The drug is designed to work in two ways to help the immune system fight cancer. Researchers will test it alone and in combination with two other approved cancer drugs to find the best dose and see if it can help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, 05505, South Korea
Contact
-
Carolina Biooncology Institute
RECRUITINGHuntersville, North Carolina, 28078, United States
Contact
-
Chungnam National University Hospital
RECRUITINGDaejeon, Daejeon, 65015, South Korea
Contact
-
Korea University Anam Hospital
RECRUITINGSeoul, Seongbuk-gu, 02841, South Korea
Contact
-
The Catholic University of Korea St. Vincent's Hospital
RECRUITINGSuwon, Kyeonggi-do, 16247, South Korea
Contact
-
Tisch Cancer Institute (TCI), Icahn School of Medicine
RECRUITINGNew York, New York, 10029-5674, United States
Contact
-
Yonsei University Health System, Severance Hospital
RECRUITINGSeoul, 03722, South Korea
-
Yonsei University Health System, Severance Hospital
RECRUITINGSeoul, 03722, South Korea
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.